Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Pilot Trial
2016-002784-34Phase 2Active
- Sponsor
- Radboudumc
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of deferoxamine in subarachnoid hemorrhage (SAH) and brain aneurysm (IA), sponsored by Radboudumc. Primary endpoint: IMP-related adverse events. Started Feb 2018; status: active.
02
Drugs
deferoxamine
03
Conditions
subarachnoid hemorrhage (SAH)brain aneurysm (IA)
Beyond the preview
Go deeper on 2016-002784-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002784-34.